77 Current news of Sartorius


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Sartorius records dynamic start to the new fiscal year

Global political and economic uncertainties substantially increased


Sartorius recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period. Based on its performance in the first three months, Sartorius confirms its outlook for fiscal 2022. “Sartorius had ...


image description
Sartorius completes acquisition of Novasep’s chromatography division

Sales revenue forecast for 2022 updated due to acquisition


Sartorius announced that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasepchromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had already been agreed upon at the beginning of 2021. The ...


image description
Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability

Number of employees rises by 30 percent to nearly 14,000


Due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions, the life science group Sartorius closed fiscal 2021 with exceptionally strong growth and a jump in profitability. According to preliminary figures, the company ...


image description
Waters and Sartorius collaborate

Companies to help bioprocess scientists accelerate clone selection and process development


Waters Corporation and Sartorius announced they will partner to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) data to accelerate the speed and improve the accuracy of biopharmaceutical process development. Sartorius and Waters will partner to implement the ...


image description
Sartorius acquires cell culture specialist Xell AG

Extension of the Sartorius cell culture media business with a focus on media for gene therapeutics and vaccines


Sartorius, through its subgroup Sartorius Stedim Biotech, acquired cell culture specialist XellAG headquartered in Bielefeld, Germany. XellAG develops, produces, and markets media and feed supplements for cell cultures, especially for manufacturing viral vectors that are used in gene ...


image description
Sartorius continues on its fast growth trajectory

Significant double-digit increases in sales and earnings


Sartorius has continued on its fast growth trajectory, closing the first half of 2021 with significant double-digit increases in both sales revenue and order intake. “In the first six months of the year, we have seen unabated high demand for innovative technologies used in the development and ...


image description
Sartorius closes 2020 with strong growth

Group management raises sales target for 2025 to about 5 billion euros


Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the year with significant double-digit growth rates in sales revenue, ...


image description
Strong profitable growth at Sartorius

Positive development of the Lab Products & Services Division


Sartorius closed the first nine months of 2020 with significant double-digit growth rates in sales revenue and earnings. “In the third quarter, we saw high demand for nearly our entire product range,” said Joachim Kreuzburg, CEO. “On top of overall strong organic growth, additional momentum was ...


image description
Purification specialist BIA Separations to become part of Sartorius

BIA Separations will be Sartorius’ center of excellence for purification of cell and gene therapeutics


Sartorius announced it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a transaction totaling 360 million euros of which 240 million euros will be paid in cash and 120 million euros in Sartorius Stedim Biotech ...


image description
Sartorius raises forecast for the full year of 2020

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group


Based on the strong performance of the Bioprocess Solutions Division in the first half of 2020 as well as on high demand also expected to continue for the rest of the current fiscal year, Sartorius raised its full-year sales and earnings guidance for this division and thus for the entire Group. ...


Page 1 From 8
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE